Vaibhav

THERAPY

Hydrogen therapy for Covid-19 acute respiratory distress syndrome (ARDS) | by Vaibhav

Vaibhav
Covid-19 rendering

In the cohort involving 201 patients with confirmed COVID-19 pneumonia, risk factors associated with the development of acute respiratory distress syndrome (ARDS) and progression from ARDS to death included older age, neutrophilia and organ and coagulation dysfunction. Recently, accumulating evidence suggests that a subgroup of patients with severe COVID-19 might have a cytokine storm syndrome and hyper inflammation. [1,2]

[A] Prof. Zhong Nanshan, Chinese scientist, epidemiologist and pulmonologist who discovered the SARS coronavirus in 2003 on benefits of the oxygen-hydrogen gas mix inhalation in Chinese patients

[B] Overview of planned or ongoing studies of drugs for the treatment of COVID-19

Hydrogen-oxygen nebulizer

[C] Duried Alwazeer, Redox Research Center, Igdir √úniversitesi on Potential Cheap and effective Drug for COVID-19

https://www.researchgate.net/post/Potential_Cheap_and_effective_Drug_for_COVID-19

Given the theory that molecular hydrogen can significantly down-regulate expressions of inflammation-related genes and selectively reduce hydroxyl radical, there are reasons to believe that cytokine storm

Read More Read More